FEATURED ARTICLE • REHABILITATION EDUCATION

Bell’s Palsy and Facial Palsy: Facial Nerve Anatomy, Assessment, Grading and Rehabilitation

A comprehensive RehabLectures guide for physiotherapy students and clinicians

SEO Title: Bell’s Palsy and Facial Palsy: Symptoms, Assessment, Grading and Physiotherapy

Meta Description: A detailed guide to Bell’s palsy and facial palsy covering CN VII anatomy, causes, LMN versus UMN findings, assessment, grading, eye care and rehabilitation.

Introduction

The uploaded source contains multiple detailed notes on Bell’s palsy and facial palsy. A central theme is the need to distinguish Bell’s palsy from facial palsy caused by another identifiable condition and to distinguish peripheral/lower motor neuron facial weakness from central/upper motor neuron weakness.

Bell’s Palsy vs Facial Palsy

Facial Nerve (Cranial Nerve VII) Anatomy

The facial nerve is cranial nerve VII. The source describes it as a mixed nerve with motor, sensory, parasympathetic and taste functions. It originates from the pons, enters the internal acoustic meatus, travels through the facial canal in the temporal bone, exits at the stylomastoid foramen and then passes through the parotid region before dividing into terminal branches.

Causes of Facial Palsy

• Bell’s palsy / idiopathic facial nerve palsy.
• Possible reactivation of herpes simplex virus discussed in the source.
• Herpes zoster / Ramsay Hunt syndrome.
• Otitis media and other ear infections.
• Trauma, including temporal-bone fracture or head injury.
• Surgical or iatrogenic injury, including procedures around the parotid, ear or neck.
• Tumors such as acoustic neuroma or parotid tumor.
• Stroke as a central/UMN cause.
• Lyme disease and other neurological conditions are listed in the source.
• Congenital causes.

Pathophysiology of Bell’s Palsy

The source describes inflammation and edema of the facial nerve within the facial canal. Because the nerve travels through a relatively narrow bony canal, swelling can increase pressure, reduce blood supply and impair nerve conduction. The resulting dysfunction produces weakness or paralysis of facial expression.

Clinical Features

• Sudden unilateral facial weakness or paralysis.
• Loss of forehead wrinkling on the affected side.
• Difficulty or inability to close the eye completely.
• Flattening of the nasolabial fold.
• Drooping of the angle of the mouth and deviation toward the normal side.
• Difficulty smiling, frowning, whistling or puffing the cheeks.
• Drooling or difficulty with drinking/eating.
• Hyperacusis when stapedius involvement is present.
• Altered taste involving the anterior two-thirds of the tongue when the lesion affects relevant fibers.
• Excess tearing or dry eye.

Central (UMN) vs Peripheral (LMN) Facial Palsy

The source places strong emphasis on localization. A peripheral/LMN facial nerve lesion affects the upper and lower parts of the ipsilateral face, including the forehead. A central/UMN lesion typically produces weakness predominantly in the contralateral lower face, with relative sparing of the forehead because of bilateral cortical input to the upper facial region.

High-yield memory aid from the source: 'Forehead off → think LMN; forehead spared → think UMN.' Always interpret this with the full neurological picture.

Assessment

Assessment should begin with onset and associated symptoms, followed by observation of facial symmetry and testing of voluntary facial movements. The source includes formal grading and additional tests when needed.

• History: onset, progression, ear pain, taste changes, hearing symptoms and other neurological complaints.
• Inspect facial symmetry at rest.
• Ask the patient to raise the eyebrows/forehead.
• Ask the patient to close the eyes tightly.
• Ask the patient to smile and show the teeth.
• Ask the patient to puff the cheeks and whistle.
• Observe nasolabial folds and mouth deviation.
• Assess facial muscle strength and functional control.
• Assess taste and tearing when indicated.
• Use an established facial-palsy grading scale.
• Refer or investigate further when atypical findings or another cause is suspected.

Grading of Facial Palsy

The source uses the House–Brackmann grading system and presents six levels, from normal function to total paralysis.

Additional Assessment Tools

• House–Brackmann Facial Nerve Grading.
• Sunnybrook Facial Grading System is mentioned in the source.
• Schirmer test for tearing when indicated.
• Electroneurography (ENoG) and EMG when clinically required.
• Taste testing when relevant.
• Audiometry when hyperacusis or hearing symptoms are present.
• MRI when a tumor or central cause is suspected.

Medical Management and Eye Care

The source lists corticosteroids such as prednisolone as medical treatment for Bell’s palsy, with treatment started early, and notes that antivirals may be added when a viral cause is suspected. Because inability to close the eye can expose the cornea to injury, eye care is a major priority.

• Lubricating eye drops/artificial tears.
• Eye ointment when prescribed.
• Eye patching, especially at night, when appropriate.
• Protection of the eye from dryness and injury.
• Medical referral for persistent or concerning eye symptoms.

Physiotherapy Rehabilitation

The source describes rehabilitation as stage-dependent. Early management emphasizes education, eye protection, gentle movement and relaxation. As recovery progresses, the program can include facial movement retraining, mirror therapy, neuromuscular re-education and carefully progressed functional facial activities.

Acute Phase: Approximately 0–2 Weeks

• Patient education and reassurance.
• Eye care and protection when eye closure is incomplete.
• Gentle facial movement within tolerance.
• Breathing and relaxation exercises.
• Gentle massage when appropriate.
• Avoid forceful or excessive facial exercise.

Subacute Phase: Approximately 2–6 Weeks

• Active-assisted and active facial movements as recovery allows.
• Mirror therapy to improve awareness and symmetry.
• Neuromuscular re-education.
• Biofeedback/EMG biofeedback when available and appropriate.
• Continue eye care.

Recovery Phase: Beyond Approximately 6 Weeks

• Progressive facial movement control and strengthening when appropriate.
• Functional practice: smiling, frowning, closing the eyes, puffing the cheeks and other facial tasks.
• Coordination and endurance training.
• Address synkinesis or abnormal movement patterns when present.
• Relaxation and stress-management strategies.

Facial Exercise Principles

The source recommends using a mirror, practicing controlled movement and avoiding excessive effort. Facial rehabilitation is not simply a matter of repeatedly forcing weak muscles. The quality and selectivity of movement should be monitored, particularly during recovery when abnormal linked movements may develop.

• Practice in front of a mirror.
• Use gentle, controlled movements.
• Aim for symmetry and selective activation.
• Avoid overexertion of weak facial muscles.
• Stop or modify exercises if abnormal movement patterns increase.
• Maintain a consistent home program.

Home Program and Patient Education

• Perform facial exercises as prescribed rather than using forceful unsupervised repetition.
• Protect the eye and follow prescribed lubrication/patching instructions.
• Maintain good oral hygiene.
• Practice facial expressions in front of a mirror.
• Use relaxation and controlled breathing to reduce unnecessary facial effort.
• Be consistent and patient because recovery may take weeks to months.

Clinical reasoning points

• Localize the weakness as peripheral versus central using the forehead, eye and lower-face findings together.
• Screen for atypical neurological features that could indicate another cause.
• Prioritize eye protection when eyelid closure is impaired.
• Use stage-appropriate facial rehabilitation rather than aggressive strengthening.

Precautions

• Protect the eye from dryness and injury.
• Avoid excessive or forceful facial exercises.
• Monitor for synkinesis or abnormal movement during recovery.
• Refer when symptoms are atypical, progressive or associated with other neurological findings.
• Coordinate medical management and physiotherapy rather than treating facial weakness in isolation.

Prognosis

The source describes Bell’s palsy as generally having a good prognosis, with approximately 70–85% complete recovery within 3–6 months in one of the supplied notes. It also identifies poorer prognostic factors such as severe paralysis, older age, diabetes and lack of improvement over the early months. Synkinesis may occur during recovery.

Key Takeaways

• Bell’s palsy is an acute idiopathic peripheral facial nerve palsy.
• Facial palsy is a broader term with multiple possible causes.
• CN VII anatomy helps localize the lesion and understand associated symptoms.
• LMN lesions involve the forehead; typical UMN lesions spare the forehead.
• Eye protection is essential when eyelid closure is impaired.
• Rehabilitation should be gentle, controlled and stage-specific.
• Early recognition and appropriate medical/rehabilitative management improve the chance of good functional recovery.

Before publication, RehabLectures should perform a final clinical review, particularly for medication details, diagnostic thresholds, treatment indications and any statements that may vary by guideline or clinical setting. The clinical case studies in this document are educational examples added to improve readability and application; they are not extracted from the uploaded source.